Word

ALEVATE

Status

Pending

Status Code

645

Status Date

Sunday, December 31, 2023

Serial Number

79350535

Mark Type

4000

Filing Date

Tuesday, May 17, 2022

Trademark Owner History

Albumedix Ltd

Classifications

41 Education, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and development; technical training in the field of medical, biological, biopharmaceutical, pharmaceutical and chemical analysis; information, consultancy and advisory services for the aforementioned services

45 Regulatory compliance auditing; advisory services on biological, pharmaceutical, biopharmaceutical, chemical, and medical regulatory affairs; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services

42 Research and development services in the field of new biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, and providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products as well as laboratory analysis services; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; trouble shooting in the nature of diagnosing problems with pharmaceutical, biopharmaceutical, chemical, and medical products, processes, and computer software, none of the foregoing related to financial software; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, quality assurance in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; quality control services for others in the field of development and testing of cells; services of a scientific chemical and biological laboratory; development and testing of chemical, pharmaceutical, biopharmaceutical, chemical, and medical production methods; quality control services for others and authentication services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, providing quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; scientific and medical laboratory services; information, consultancy and advisory services for research, testing, and development in the pharmaceutical, biopharmaceutical, chemical, and medical fields, none of the foregoing related to financial software

Trademark Events

Mar 18, 2024

Notification Of Possible Opposition - Processed By Ib

Feb 28, 2024

Notification Of Possible Opposition Sent To Ib

Feb 28, 2024

Notification Of Possible Opposition Created, To Be Sent To Ib

Dec 31, 2023

Notification Of Final Refusal Emailed

Dec 31, 2023

Final Refusal E-Mailed

Dec 31, 2023

Final Refusal Written

Nov 3, 2023

Teas/Email Correspondence Entered

Nov 3, 2023

Correspondence Received In Law Office

Nov 3, 2023

Teas Response To Office Action Received

May 24, 2023

Refusal Processed By Ib

May 4, 2023

Non-Final Action Mailed - Refusal Sent To Ib

May 4, 2023

Refusal Processed By Mpu

Apr 2, 2023

New Representative At Ib Received

Mar 16, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Mar 15, 2023

Non-Final Action Written

Mar 7, 2023

Assigned To Examiner

Jan 29, 2023

New Representative At Ib Received

Sep 27, 2022

Application Filing Receipt Mailed

Sep 23, 2022

New Application Office Supplied Data Entered

Sep 22, 2022

Sn Assigned For Sect 66a Appl From Ib